Assessing efficacy of L-carnitine supplementation to treat muscle fatigue and weakness in children with NF1. A placebo controlled, blinded clinical trial

syn60244968

Created By NF Service nf-osi-service

grantDOI: https://doi.org/10.48105/CTF.2023-04-004.pc.gr.188710
studyName: Assessing efficacy of L-carnitine supplementation to treat muscle fatigue and weakness in children with NF1. A placebo controlled, blinded clinical trial
dataStatus: Data Pending
initiative: Contract Award
studyLeads: Yemima Berman
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
institutions: TBD
fundingAgency: CTF
manifestation: Quality of Life
studyFileviewId: syn60244975
syn60244969
syn60504138
syn60244970
syn60244975
syn60244971

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Assessing efficacy of L-carnitine supplementation to treat muscle fatigue and weakness in children with NF1. A placebo controlled, blinded clinical trial page is loading…

Assessing efficacy of L-carnitine supplementation to treat muscle fatigue and weakness in children with NF1. A placebo controlled, blinded clinical trial

syn60244968

Drop files to upload

Assessing efficacy of L-carnitine supplementation to treat muscle fatigue and weakness in children with NF1. A placebo controlled, blinded clinical trial page is loading…